Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
Neidert MC, Schoor O, Trautwein C, Trautwein N, Christ L, Melms A, Honegger J, Rammensee HG, Herold-Mende C, Dietrich PY, Stevanović S.
Neidert MC, et al. Among authors: schoor o.
J Neurooncol. 2013 Feb;111(3):285-94. doi: 10.1007/s11060-012-1028-8. Epub 2012 Dec 23.
J Neurooncol. 2013.
PMID: 23263746